LAP3 and COVID-19: The need to take into consideration involvement of substance P and neurotensin is further emphasized by Garvin et al. data suggesting downregulation of another peptidase neprilysin in COVID‐19 patients, since this enzyme also, similar to ACE, inactivates bradykinin, substance P and neurotensin.